Multiple sclerosis drugs on Blue MedicareRx Premier (S2893-003)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Connecticut + 3 more
- Premium
- $238.60/month
- Deductible
- None
2 of 8 Multiple sclerosis drugs are covered on this plan. All 2 require prior authorization.
6 aren't on the formulary, including teriflunomide and dimethyl fumarate.
- $4,245.35Tier 5
- $1,866.34Tier 5
Not on the formulary
teriflunomide, dimethyl fumarate, Vumerity, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.